Polycyclic cinnamide derivative

Disclosed is a compound represented by the formula (I) or a pharmacologically acceptable salt thereof: (I) wherein Ar1 represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like; Ar2 represents a phenyl group which may be substituted by a C1-6 alkoxy group, or the lik...

Full description

Saved in:
Bibliographic Details
Main Authors DOKO TAKASHI, KITAZAWA NORITAKA, KAWANO KOKI, KANEKO TOSHIHIKO, KIMURA TEIJI, SASAKI TAKEO, DOI ERIKO, ITO KOICHI, HAGIWARA HIROAKI, SATO NOBUAKI, MIYAGAWA TAKEHIKO, TAKAISHI MAMORU
Format Patent
LanguageChinese
English
Published 01.04.2009
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a compound represented by the formula (I) or a pharmacologically acceptable salt thereof: (I) wherein Ar1 represents an imidazolyl group which may be substituted by a C1-6 alkyl group, or the like; Ar2 represents a phenyl group which may be substituted by a C1-6 alkoxy group, or the like; X1 represents a double bond or the like; and Het represents an imidazolyl group which may be substituted by a C1-6 alkyl group or the like, or the like. The compound or the salt is effective as a therapeutic or prophylactic agent for a disease associated with Ass.
Bibliography:Application Number: CN200780008382